Trial intelligence / Profile preview

Zataria multiflora essential oil versus albendazole for hepatic hydatid cyst

IRCT20180219038798N1Phase 2Completed

Sponsor
Shiraz University
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of albendazole in cystic echinococcosis (CE) and hepatic echinococcosis (HE) (2 arms), sponsored by Shiraz University. Primary endpoint: Reduction in hydatid cyst size. Started Apr 2015; status: completed.

02

Drugs

albendazole
03

Conditions

cystic echinococcosis (CE)hepatic echinococcosis (HE)

Beyond the preview

Go deeper on IRCT20180219038798N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180219038798N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call